Skip to main navigation Skip to search Skip to main content

Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study

  • Stefano Piaserico*
  • , Paolo Gisondi
  • , Clara De Simone
  • , Elena Marinello
  • , Andrea Conti
  • , Paolo Amerio
  • , Andrea Peserico
  • *Corresponding author
  • University of Padua
  • University of Verona
  • University of Modena and Reggio Emilia
  • Gabriele d'Annunzio University

Research output: Contribution to journalArticle

Abstract

N/A
Original languageEnglish
Pages (from-to)251-252
Number of pages2
JournalActa Dermato-Venereologica
Volume96
Issue number2
DOIs
Publication statusPublished - 2016

All Science Journal Classification (ASJC) codes

  • Dermatology

Keywords

  • 2708
  • Adalimumab
  • Adult
  • Aged
  • Anti-Inflammatory Agents
  • Dermatologic Agents
  • Etanercept
  • Female
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Psoriasis
  • Recurrence
  • Remission Induction
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha

Fingerprint

Dive into the research topics of 'Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study'. Together they form a unique fingerprint.

Cite this